Click on headlines below to download research

Nootkatone EPA registration complete
Evolva | 11/08/2020

Evolva’s branded nootkatone has now been registered with the US Environmental Protection Agency (EPA) for use in insecticides and insect repellents.…

Focus on existing holdings and EOS VC Fund
FinLab | 03/08/2020

FinLab has recently continued to focus on adding value to its existing fintech investments and expanding its portfolio of blockchain projects through the…

Maintaining FY20 profit target
Mensch & Maschine Software | 24/07/2020

Mensch und Maschine has reported a respectable set of H120 results, with revenue growth of 8.5% and EPS growth of 19.0% y-o-y. Q2 suffered from weaker…

Striding towards major inflection points
MagForce | 20/07/2020

MagForce, a pioneer in nanotechnology-based cancer treatments, is making steady progress with its strategy to drive the uptake of its thermal ablation…

Proposed merger with SGT Capital
German Startups Group | 17/07/2020

German Startups Group (GSG) announced last Wednesday its intention to merge with SGT Capital, a global alternative investment and private equity asset…

Machine tools market under pressure
DVS Technology | 14/07/2020

Significantly weaker markets and increased costs ahead of a ramp up in production, drove DVS TECHNOLOGY’s 2019 revenue and reported EBIT down 1%…

Recovering in favourable market conditions
The NAGA Group | 13/07/2020

NAGA recorded a heavy EBITDA loss in FY19, affected by adverse market conditions and a significant decline in revenues from services from Naga Development…

Key inflection points on the horizon
MagForce | 13/07/2020

MagForce, a pioneer in nanotechnology-based cancer treatments, is making steady progress with its strategy to drive the uptake of its thermal ablation…

Reverse takeover potential
mic | 09/07/2020

mic is considering a reverse acquisition to shift from a holding company to an operational company. The FY19 results showed an improvement in gross profit,…

Mixed media markets
Edel | 08/07/2020

Edel’s H120 figures showed a 3% uplift in revenues versus H119, but at a slightly lower gross margin reflecting the shift in mix. Kontor New Media…

ByFavo – poised for autumn US launch
Paion | 07/07/2020

In a breakthrough achievement for Paion, the FDA has approved ByFavo (remimazolam) for US sale for procedural sedation (PS) taking under 30 minutes –…

Nootkatone green light nears
Evolva | 03/07/2020

A 15-day public review period for nootkatone has started in the US. All studies submitted to the US Environment Protection Agency (EPA) have been accepted…

Further buybacks likely
German Startups Group | 29/06/2020

Following the successful disposal of Exozet in December 2019 as well as a few exits from its VC portfolio last year, German Startups Group (GSG) held a…

Entertaining through lockdown
Pantaflix | 24/06/2020

Pantaflix expects a tough FY20, followed by a strong recovery in FY21. The COVID-19 shutdown has disrupted current productions and the release of previously…

Waiting for the regulatory go-ahead
Flatex | 23/06/2020

Flatex reported FY19 of earnings €14.9m (-15% y-o-y) and a ROE of 8.6%. Lower market volatility affected the results, as did the costs of expansion…

Changing gear
Williams Grand Prix | 16/06/2020

In terms of the Formula One racing performance, 2019 was another challenging year on the track as well as financially. Williams also disposed of a majority…

Carrying sales momentum into FY20
artec technologies | 12/06/2020

FY19 revenues of €2.0m were weaker than management expected due to a small number of material contracts failing to materialise by year-end. However,…

New business focus should benefit FY20
Daldrup & Söhne | 11/06/2020

FY19 was a year of significant change for Daldrup & Söhne (D&S), marked by the disposal of Geysir Europe. With a strengthened balance sheet, a renewed…

Non-destructive measurement technology
Nynomic | 10/06/2020

While noting the uncertainty caused by the coronavirus pandemic, management believes that Nynomic is comparatively robust because of the diversity of markets…

Compassionate COVID-19 ICU use in Italy
Paion | 09/06/2020

As we await the FDA verdict on ByFavo (remimazolam) for procedural sedation (PS) due 5 July 2020, Paion announced in June that it will provide remimazolam…

Steady increase in NAV and stable dividend
Blue Cap | 09/06/2020

Blue Cap reported a strong set of FY19 results, with revenues up 28% and adjusted EBITDA up 67%. Portfolio NAV increased 8% to €128.6m or €32.31…

Strong demand for data centre intelligence
Beta Systems | 04/06/2020

Beta Systems, a software provider for data centre intelligence (DCI) and identity access management (IAM), has reported both strong organic and inorganic…

Healthy performance fee and dividend income
ÖKOWORLD | 29/05/2020

Following muted results in FY18, ÖKOWORLD (ÖWAG) reported significant top- and bottom-line expansion in FY19, driven by a €2.8m improvement…

New valuations look conservative
Deutsche Beteiligungs | 29/05/2020

Deutsche Beteiligungs (DBAG) has updated its portfolio values, which led to a considerable revaluation loss in Q220, and in turn a net loss for H120 at…

Absorbing acquisitions with a robust model
DATAGROUP | 29/05/2020

DATAGROUP’s business model is relatively resilient to the COVID-19 crisis with a recurring revenue base of over 75%, mostly from its service-as-a-product…